Bioxytran (BIXT) Assets (2010 - 2026)
Bioxytran (BIXT) recorded Assets of $333,393 in Q2 2026, up 126.0% from $147,501 a year earlier but down 45.8% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran reported Assets of $658,552, up 374.8% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 15.1% (FY2020 to FY2025).
- Across earlier years, Assets came in at $138,694 in FY2024 (-0.5%), $139,382 in FY2023 (-62.4%), $370,936 in FY2022 (+211.0%) and $119,290 in FY2021 (-63.5%).
- Quarterly Assets has ranged from $119,290 in Q4 2021 to $807,927 in Q1 2022 over the past five years.
- On a year-over-year basis, Assets has increased for three consecutive quarters, with growth averaging 107.3% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 374.8% in Q4 2025, against a decline of 74.8% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $615,253 (Q1 2026), $658,552 (Q4 2025) and $156,294 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 333,393.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 333,393.00 |
| Mar 31, 2026 | 615,253.00 |
| Dec 31, 2025 | 658,552.00 |
| Sep 30, 2025 | 156,294.00 |
| Jun 30, 2025 | 147,501.00 |
| Mar 31, 2025 | 136,052.00 |
| Dec 31, 2024 | 138,694.00 |
| Sep 30, 2024 | 159,008.00 |
| Jun 30, 2024 | 128,553.00 |
| Mar 31, 2024 | 125,540.00 |
| Dec 31, 2023 | 139,382.00 |
| Sep 30, 2023 | 189,043.00 |
| Jun 30, 2023 | 143,061.00 |
| Mar 31, 2023 | 233,533.00 |
| Dec 31, 2022 | 370,936.00 |
| Sep 30, 2022 | 448,539.00 |
| Jun 30, 2022 | 568,225.00 |
| Mar 31, 2022 | 807,927.00 |
| Dec 31, 2021 | 119,290.00 |
| Sep 30, 2021 | 762,248.00 |
API Access
Bioxytran Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();